First Horizon Corporation’s Corcept Therapeutics CORT Stock Holding History

First Horizon Corporation’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870	Buy	+10	New	+$604	﹤0.01%	1431
2026 Q1	–	Sell	-6	Closed	-$209	–	1482
2025 Q4	$209	Hold	6	–	–	﹤0.01%	1453
2025 Q3	$499	Buy	+6	New	+$434	﹤0.01%	1365
2021 Q2	$0	Hold	14	–	–	﹤0.01%	1090
2021 Q1	$0	Hold	14	–	–	﹤0.01%	1074
2020 Q4	$0	Hold	14	–	–	﹤0.01%	1068
2020 Q3	$0	Buy	+14	New	+$223	﹤0.01%	1038

Other funds holding CORT

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

First Horizon Corporation's CORT Position: Q2 2026 in Review

First Horizon Corporation opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 10 shares worth $870. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: First Horizon Corporation previously reported a position in CORT as recently as Q4 2025.

First Horizon Corporation first reported a position in CORT in Q3 2020 and has held it in 7 quarters since. 113 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

First Horizon Corporation held 10 shares of Corcept Therapeutics worth $870 as of Q2 2026.
Corcept Therapeutics was a new First Horizon Corporation position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1431 holding.
First Horizon Corporation first reported a position in Corcept Therapeutics in Q3 2020 and has held it in 7 quarters since.
113 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.